Synergy Pharma (SGYP) Posts Q1 Loss of 18c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Synergy Pharma (SGYP) Posts Q1 Loss of 18c/Share

Aegis Trims PT on Synergy (SGYP) to $26 Following Q1 Results; Updates on N-T Catalysts

May 14, 2014 10:02 AM EDT

Aegis Capital cuts its price target on Synergy Pharmaceuticals (Nasdaq: SGYP) from $28 down to $26 while affirming its Buy rating.

Analyst Ram Selvaraju noted that Synergy's Q1 loss of $.18 per share was narrower than his expected loss of $.23 per share, based on lower R&D and G&A spending.

Selvaraju also highlighted near-term catalysts for... More